NRG1 and xeroderma pigmentosum: This test detects mutations in CDK5RAP2, NRG1, and NIPBL genes involved in neurodevelopmental or neurodegenerative processes and confirms the same pattern in all proven CS / XP patients neurological symptoms or but not observed in mutations in XP genes associated with dermatological symptoms.